All of these stocks are down more than 10% in the past four weeks.
News & Analysis: Seagen Inc.
A broad market sell-off is trumping third-quarter results that outpaced analyst expectations.
SGEN earnings call for the period ending September 30, 2020.
Investors celebrated news of a big partnership -- and a big capital infusion.
Prep your portfolio by buying shares of healthcare companies that can deliver revenue growth in the worst of times.
Merck is acquiring $1 billion in Seattle Genetics shares as part of a wide-ranging collaboration agreement.
SGEN earnings call for the period ending June 30, 2020.
Two drug approvals in just a few months gave investors reason to cheer.
These companies have products, products, and more products to keep revenue flowing.
SGEN earnings call for the period ending March 31, 2020.